Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BETd-260是一种 PROTAC,由 Cereblon 配体和 BET 配体相连,对白血病细胞株 BRD4蛋白的抑制作用。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 1,990 | 现货 | ||
5 mg | ¥ 3,990 | 现货 | ||
10 mg | ¥ 5,680 | 现货 | ||
25 mg | ¥ 8,730 | 现货 | ||
50 mg | ¥ 11,700 | 现货 |
产品描述 | BETd-260, a PROTAC linked by a Cereblon ligand and a BET ligand, has an inhibitory effect on BRD4 protein in leukemic cell lines. |
靶点活性 | BRD3:30-100 pM, BRD:0.0022 μM, BRD2:30-100 pM, BRD4:<30 pM |
体外活性 | betd - 260 (ZBC260; Compound 23) induced the degradation of BRD2, BRD3 and BRD4 proteins. BETd-260 acted on RS4; The ic50 measured for 11 leukemic cells was 51 pM. The ic50 of BETd-260 in MOLM-13 cells was 2.2 nM. BETd-260 at 3-10 nM could induce RS4; 11 and MOLM-13 cell apoptosis. Moreover, BETd-260 inhibited the transcription and translation of anti-apoptotic genes Mcl-1, Bcl-2, c-Myc and XIAP and increased the transcription and translation of pro-apoptotic gene Bad in HCC cells[1]. |
体内活性 | BETd-260 (5 mg/kg, i.v.) degrades the BRD2, BRD3, and BRD4 proteins for more than 24 h, with robust cleavage of PARP and caspase-3, and strong down-regulation of c-Myc protein in RS4;11 xenograft mice model[1]. BETd-260 (5 mg/kg, i.v., every other day, thrice a week for 3 weeks) causes rapid tumor regression with a maximum of >90% regression in mice bearing RS4;11 xenograft tumors, and with no body weight loss or other signs of toxicity in mice. |
别名 | ZBC 260 |
分子量 | 798.89 |
分子式 | C43H46N10O6 |
CAS No. | 2093388-62-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 22.5 mg/mL (28.2 mM), Sonication is recommended.
H2O: 0.1 mg/mL, insoluble
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 1.2517 mL | 6.2587 mL | 12.5174 mL | 31.2934 mL |
5 mM | 0.2503 mL | 1.2517 mL | 2.5035 mL | 6.2587 mL | |
10 mM | 0.1252 mL | 0.6259 mL | 1.2517 mL | 3.1293 mL | |
20 mM | 0.0626 mL | 0.3129 mL | 0.6259 mL | 1.5647 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
BETd-260 2093388-62-4 Chromatin/Epigenetic Epigenetic Reader Domain ZBC260 ZBC-260 ZBC 260 Inhibitor inhibitor inhibit